Xolair: A New Monoclonal Drug Anti-IgE Antibody for the Treatment of Allergic Asthma
Respiratory and Physiopathology Department, Cava de’ Tirreni Hospital, Italy
Biography:
Dr. Monica Di Domenico from the Department of Respiratory and Physiopathology and he completed gardution at the University of Salerno
Italy.He Specialization in physiopathology and Respiratory and he working at Cava de’ Tirreni Hospital, Italy and Him One Of The Contribution is Xolair: A New Monoclonal Drug Anti-IgE Antibody for the Treatment of Allergic Asthma
Subjects of specialization: Physiopathology, Respiratory